Abivax SA (ADR) share price logo

Abivax SA (ADR)

NASDAQ: ABVX

Large Cap

$144.65

+12.09

(+9.12%)

as on

Abivax SA (ADR) Stock Performance

as on July 3, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $137.95
    $146.68
    downward going graph

    4.63%

    Downside

    1.40%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $7.65
    $148.83
    downward going graph

    94.71%

    Downside

    2.89%

    Upside

    downward going graph

Abivax SA (ADR) share price movements today

Previous Close
$132.56
Open
$138.10
Volume
3.2M
Day's Low - High
$137.95 - $146.68
52 Week Low - High
$7.65 - $148.83

Abivax SA (ADR) Historical Returns

1 Month Return
+ 60.45 %
3 Month Return
+ 22.2 %
1 Year Return
+ 1717.21 %
3 Year Return
0 %
5 Year Return
0 %

Abivax SA (ADR) Stock Fundamentals & Key Indicators

Check Abivax SA (ADR) market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$10.6B

EPS (TTM)

-3.643

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-254.0M

Revenue (TTM)

4.9M

Profit Margin

0.00%

Return On Equity TTM

-157.07%

Abivax SA (ADR) vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Abivax SA (ADR) with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Abivax SA (ADR) image
Abivax SA (ADR)
BUY$10.6BNANA0.00%NA
Revolution Medicines Inc. image
Revolution Medicines Inc.
BUY$39.9B478.19%NA0.00%NA
Alnylam Pharmaceuticals Inc. image
Alnylam Pharmaceuticals Inc.
BUY$40.3B82.45%75.812.55%NA
Vertex Pharmaceuticals Inc. image
Vertex Pharmaceuticals Inc.
BUY$126.4B163.31%29.5935.51%NA
Regeneron Pharmaceuticals Inc. image
Regeneron Pharmaceuticals Inc.
BUY$65.5B12.1%15.2529.65%0.5700000000000001%

Stock Returns calculator for Abivax SA (ADR) Stock including INR - Dollar returns

The Abivax SA (ADR) stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

Abivax SA (ADR) investment value today

Current value as on today

₹20,23,457

Returns

₹19,23,457

(+1.92K%)

Returns from Abivax SA (ADR) Stock

₹17,17,211 (+1.72K%)

Dollar Impact

₹2,06,246 (+206.25%)

Analyst Recommendation on Abivax SA (ADR) Stock

Based on 14 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 14 analysts, 85.71% of analysts recommend a 'BUY' rating for Abivax SA (ADR). Average target price of $160.09

Abivax SA (ADR) Share Price Target

Get share price movements and forecasts by analysts on Abivax SA (ADR).

What analysts predicted

9.64%UPSIDE

Target Price

$160.09

Current Price

$144.65

Analyzed by

14 Analysts

Target

$160.09

Abivax SA (ADR) target price $160.09, a slight upside of 9.64% compared to current price of $144.65. According to 14 analysts rating.

Indian Investors' Interest in Abivax SA (ADR) Stock

Investment in Abivax SA (ADR) Shares on INDmoney has grown by 1472.41% in the last 30 days, indicating increased investment activity.

Time period: to

Change:1472.41% versus previous 30 day period

Search interest for Abivax SA (ADR) Stock has increased by 1464% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:1464% versus previous 30 day period

Abivax SA (ADR) Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
2
-
3
-
7
-
2
-
-2
-
Gross Profit
2
-
3
-
7
-
2
-
-3
-
Operating Income
-92
-44
-35
-50
-47
-47
-46
-80
-199
-56
EBITDA
-92
-
-34
-
-47
-
-44
-
-256
-
Interest Expense
5
2
3
4
4
4
3
4
15
2
Depreciation
-
0
0
0
0
0
0
0
0
0
Income Before Tax
-98
-42
-38
-55
-52
-52
-48
-153
-281
-48
Income Tax Expense
-2
-
-
-
-
-
-
-
5
-
Net Income
-104
-46
-41
-61
-54
-56
-48
-153
-287
-48
Net Profit Margin
-4118.10%
0.00%
-1142.68%
0.00%
-707.80%
0.00%
-2400.30%
0.00%
14263.16%
0.00%

Abivax SA (ADR) Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
0
0
0
0
0
0
4
5
11
-
Gross Profit
-15
-17
-17
-31
-41
-51
-53
4
11
-1
Operating Income
-18
-14
-19
-33
-38
-41
-64
-127
-172
-246
EBITDA
-17
-13
-19
-33
-37
-38
-53
-133
-162
-300
Interest Expense
0
0
0
1
2
3
6
13
12
28
Depreciation
-
-
-
0
0
0
0
0
1
1
Income Before Tax
-17
-14
-19
-34
-40
-42
-60
-147
-176
-330
Income Tax Expense
-3
-2
-3
-4
-2
-4
-4
-4
-
5
Net Income
-15
-13
-17
-34
-45
-47
-64
-161
-184
-336
Net Profit Margin
-11266.14%
-112230.00%
-87905.56%
-1531700.00%
-59604.76%
-114735.14%
-1325.33%
-3197.14%
-1633.08%
0.00%

Abivax SA (ADR) Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-42
-40
-55
-94
-52
-100
-153
-222
-48
Operating Cash Flow
-34
-42
-35
-68
-33
-66
-71
-71
-50
Investing Cash Flow
-
13
-
1
-
1
-
3
-
Financing Cash Flow
21
40
-6
-12
-7
-8
603
603
0
Change in Cash
-10
-19
-41
-40
-40
60
528
528
-39

Abivax SA (ADR) Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-14
-19
-33
-38
-42
-60
-147
-176
-322
Operating Cash Flow
-8
-14
-27
-29
-45
-53
-100
-154
-155
Investing Cash Flow
0
0
0
0
-1
-12
-10
15
-13
Financing Cash Flow
2
10
24
49
78
32
340
28
531
Change in Cash
-5
-4
-3
19
31
-33
224
-107
389

Global Institutional Holdings in Abivax SA (ADR)

Funds
Holdings
Darwin Global Management, Ltd.
4.37%
Vestal Point Capital LP
1.89%
Westfield Capital Management Company, L.P.
1.67%
Eversept Partners, LP
1.18%
HHG PLC
1.11%
See all

Abivax SA (ADR) News & Key Events

  • img

    Today's Timeline - 01 July

    Wed, 03:42 PM

    -

    Jefferies upgrades Abivax to buy, raising price target to $158 after positive obefazimod data.

    Wed, 06:12 PM

    -

    Abivax announces upsized $800M ADS offering, extending cash runway into Q2 2029.

Insights on Abivax SA (ADR)

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -287.68M → -48.46M (in $), with an average increase of 493.6% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, ABVX stock has moved up by 48.4%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, ABVX has outperformed top 5 stocks with highest market-cap in its industry

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 3 quarters, 7.39M → -2.01M (in $), with an average decrease of 136.4% per quarter

About Abivax SA (ADR)

ABIVAX Société Anonyme, a clinical-stage biotechnology company, develops therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod, which is in Phase 3 clinical development for the treatment of moderately to severely active UC, as well as Phase 2b clinical trials for Crohn's disease. The company was incorporated in 2013 and is headquartered in Paris, France.
OrganisationAbivax SA (ADR)
Headquarters7-11 Boulevard Haussmann, Paris, France, 75009
IndustryBiotechnology
CEOMr. Marc M. P. de Garidel M.B.A.
E-voting on sharesClick here to vote

Key Management of Abivax SA (ADR)

Name

Title

Ms. Ida Hatoum

Chief People & Compliance Officer

Mr. Pierre Courteille M.B.A.

Chief Business Officer

Mary Mantock

Senior VP & Global Head of Regulatory Affairs

Dr. Douglas Jacobstein M.D.

Senior VP & Global Head of Clinical Development

Mr. Marc M. P. de Garidel M.B.A.

CEO & Director

Mr. Didier Blondel

EVP, CFO & Board Secretary

Mr. Jerome Denis Ph.D.

Executive Vice President of Process Development & Manufacturing

Hema Keshava

Senior Vice President of Finance

Chris Rabbat Ph.D.

VP & Global Head of Medical Affairs

Kevin Shan Ph.D.

VP & Global Head of Biometrics

FAQs

What is Abivax SA (ADR) share price today?

Abivax SA (ADR) share price today is $144.65 as on at the close of the market. Abivax SA (ADR) share today touched a day high of $146.68 and a low of $137.95.

What is the 52 week high and 52 week low for Abivax SA (ADR) share?

Abivax SA (ADR) share touched a 52 week high of $148.83 on and a 52 week low of $7.65 on . Abivax SA (ADR) stock price today i.e. is closed at $144.65,which is 2.81% down from its 52 week high and 1792.09% up from its 52 week low.

What is Abivax SA (ADR)'s market capitalisation today?

Abivax SA (ADR) market capitalisation is $0.01T as on .

How to invest in Abivax SA (ADR) Stock (ABVX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Abivax SA (ADR) on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Abivax SA (ADR) Shares that will get you 0.0104 shares as per Abivax SA (ADR) share price of $144.65 per share as on July 3, 2026 at 8:46 am IST.

What is the minimum amount required to buy Abivax SA (ADR) Stock (ABVX) from India?

Indian investors can start investing in Abivax SA (ADR) (ABVX) shares with as little as ₹95.2 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹952.00 in Abivax SA (ADR) stock (as per the Rupee-Dollar exchange rate as on ). Based on Abivax SA (ADR) share’s latest price of $144.65 as on July 3, 2026 at 8:46 am IST, you will get 0.0691 shares of Abivax SA (ADR). Learn more about fractional shares .